Fitness Trackers During and After Oncological Treatments

University Hospital Tuebingen

Status: Unknown

Conditions: Physical Activity; Cancer; Fatigue

Treatments: Device: Fitness Tracker

Study type: Interventional

Funder types: Other

Identifiers

NCT03610854

GIROfit 1

Details and patient eligibility

About

The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically confirmed malignant disease
• Upcoming chemotherapy of radiochemotherapy
• Eastern Co-operative Oncology Group (ECOG) performance score 0-2

Exclusion criteria

• Pre-existing comorbidities that impair patient mobility.
• Eastern Co-operative Oncology Group (ECOG) performance score 3-4

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Fitness tracker Arm

Experimental group

Description:

Patients will be wearing a commercially available fitness tracker during radiotherapy or chemotherapy and four weeks after the end of treatment.

Treatment:

Device: Fitness Tracker